Aquestive Therapeutics, Inc. AQST Deferred Tax Assets
Deferred Tax Assets at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost.
The official record: Aquestive Therapeutics, Inc.’s 10-K, filed March 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s deferred tax assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s deferred tax assets?
- Aquestive Therapeutics, Inc. (AQST) reported deferred tax assets of $2.97M in Q4 2025.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s deferred tax assets?
- Over 2 years (2023 to 2025), Aquestive Therapeutics, Inc.'s deferred tax assets has grown at a -32.6% compound annual growth rate (CAGR), from $6.53M to $2.97M.
- What does deferred tax assets mean?
- Future tax benefits from temporary differences, net operating loss carryforwards, and tax credit carryforwards that will reduce future tax payments.